The influence of contrast media on kidney function in patients with stable coronary artery disease

References

• Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc. 2004;79:211–9.
   PubMed Web of Science ®Google Scholar
• Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl. 2006;(100):S3–S7.
   Google Scholar
• Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–6.
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.
   PubMed Web of Science ®Google Scholar
• Lindsay J, Apple S, Pinnow EE, Gevorkian N, Gruberg L, Satler LF, et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv. 2003;59:338–43.
   PubMed Web of Science ®Google Scholar
• Szczech LA, Best PJ, Crowley E, Brooks MM, Berger PB, Bittner V, et al. Outcomes of Patients With Chronic Renal Insufficiency in the bypass angioplasty revascularization investigation. Circulation. 2002;105:2253–8.
   PubMed Web of Science ®Google Scholar
• Chong E, Poh KK, Liang S, Soon CY, Tan HC. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol. 2010;23:451–9.
   PubMed Web of Science ®Google Scholar
• Burchardt P, Guzik P, Tabaczewski P, Synowiec T, Bogdan M, Faner P, et al. Early renal dysfunction after contrast media administration despite prophylactic hydration. Int J Cardiovasc Imaging. 2013;29:959–66.
   PubMed Web of Science ®Google Scholar
• Kong DG, Hou YF, Ma LL, Yao DK, Wang LX. Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial. Acta Cardiol. 2012;67:565–9.
   PubMed Web of Science ®Google Scholar
• Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86:649–52.
   PubMed Web of Science ®Google Scholar
• Robert AM, Brown JR, Sidhu MS, Ramanath VS, DeVries JT, Jayne JE, et al. The evaluation of creatinine clearance, estimated glomerular filtration rate and serum creatinine in predicting contrast-induced acute kidney injury among patients undergoing percutaneous coronary intervention. Cardiovasc Revasc Med. 2012;13:3–10.
   PubMedGoogle Scholar
• Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–72.
   PubMed Web of Science ®Google Scholar
• KDOQI guideline 2000 Available from: http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g1.htm. Accessed on first: January 2011, last: May 2014.
   Google Scholar
• Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–41.
   PubMed Web of Science ®Google Scholar
• Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95:13–9.
   PubMed Web of Science ®Google Scholar
• Guitterez NV, Diaz A, Timmis GC, O’Neill WW, Stevens MA, Sandberg KR, et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol. 2002;15:349–54.
   PubMedGoogle Scholar
• McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv. 2006;67:335–43.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–75.
   PubMed Web of Science ®Google Scholar
• Chong E, Poh KK, Liang S, Tan HC. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Ann Acad Med Singapore. 2010;39: 374–80.
   PubMed Web of Science ®Google Scholar
• Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90:1068–73.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98:27K–36K.
   PubMed Web of Science ®Google Scholar
• Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;(100):S11–S15.
   Google Scholar
• Nunag M, Brogan M, Garrick R. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization. Cardiol Rev. 2009;17:263–9.
   PubMed Web of Science ®Google Scholar
• Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.
   PubMed Web of Science ®Google Scholar
• Khan E, Batuman V, Lertora JJ. Emergence of biomarkers in nephropharmacology. Biomark Med. 2010;4:805–14.
   PubMed Web of Science ®Google Scholar